Mean remaining life span: A new clinically relevant parameter to assess the quality of transfused red blood cells

Transfusion

Volumn 54, Issue 1, 2014, Pages 2724-2729

  Kuruvilla, Denison J ^a   Nalbant, Demet ^b   Widness, John A ^b   Veng Pedersen, Peter ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANEMIA; ARTICLE; CELL SURVIVAL; DIABETIC PATIENT; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; HUMAN; PARAMETERS; QUALITY CONTROL; SHELF LIFE; SICKLE CELL ANEMIA; STEADY STATE; TRANSFUSED RED BLOOD CELL SURVIVAL; ADULT; ANEMIA, SICKLE CELL; BLOOD BANK; BLOOD STORAGE; BLOOD TRANSFUSION; CYTOLOGY; DIABETES MELLITUS; ERYTHROCYTE; HEALTH CARE QUALITY; PROCEDURES; STANDARDS; THEORETICAL MODEL;

ADULT; ALGORITHMS; ANEMIA, SICKLE CELL; BLOOD BANKS; BLOOD PRESERVATION; BLOOD TRANSFUSION; CELL SURVIVAL; DIABETES MELLITUS; ERYTHROCYTES; HUMANS; MODELS, THEORETICAL; QUALITY ASSURANCE, HEALTH CARE;

EID: 84908470264     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12562     Document Type: Article

References (17)

1. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 11th ed. Strasbourg: Council of Europe Publishing; 2005.
2. Hess JR, Hill HR, Oliver CK, et al. Twelve-week RBC storage. Transfusion 2003; 43: 867-872.
3. Högman CF, Meryman HT,. Red blood cells intended for transfusion: quality criteria revisited. Transfusion 2006; 46: 137-142.
4. Food and Drug Administration, Blood Products Advisory Committee. Dating of irradiated red blood cells. 2004. [cited 2014 Jan 29]. Available from: http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4057b1-02.pdf
5. Dumont LJ, AuBuchon JP,. Biomedical Excellence for Safer Transfusion C. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008; 48: 1053-1060.
6. Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008; 112: 4284-4291.
7. Lindsell CJ, Franco RS, Smith EP, et al. A method for the continuous calculation of the age of labeled red blood cells. Am J Hematol 2008; 83: 454-457.
8. Recommended method for radioisotope red-cell survival studies. International Committee for Standardization in Haematology. Br J Haematol 1980; 45: 659-666.
9. Eadie GS, Brown IW,. Analytical review: red blood cell survival studies. Blood 1953; 8: 1110-1136.
10. Veng-Pedersen P,. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II). Clin Pharmacokinet 1989; 17: 424-440.
11. Veng-Pedersen P,. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I). Clin Pharmacokinet 1989; 17: 345-366.
12. Brown IW Jr, Hardin HF,. Recovery and in vivo survival of human red cells: studies of red cells after storage up to six and one-fourth months at subzero temperatures. Arch Surg 1953; 66: 267-282.
13. Franco RS, Yasin Z, Palascak MB, et al. The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood 2006; 108: 1073-1076.
14. Pasini EM, Kirkegaard M, Mortensen P, et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006; 108: 791-801.
15. Bryszewska M, Zavodnik IB, Niekurzak A, et al. Oxidative processes in red blood cells from normal and diabetic individuals. Biochem Mol Biol Int 1995; 37: 345-354.
16. Sivilotti ML,. Oxidant stress and haemolysis of the human erythrocyte. Toxicol Rev 2004; 23: 169-188.
17. D'Almeida Mark S, Gray D, Martin C, et al. Effect of prophylactic transfusion of stored RBCs on oxygen reserve in response to acute isovolemic hemorrhage in a rodent model. Transfusion 2001; 41: 950-956.